Permanently Discontinued

APO CLOXI CAP 500MG

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO CLOXI CAP 500MG discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO CLOXI CAP 500MG has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO CLOXI CAP 500MG not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength500MG

Last updated2017-10-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ORBENIN CAP 500MG

AYERST LABORATORIES

500MG · DIN 00002054

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ORBENIN 500 CAP 500MG

WYETH-AYERST CANADA INC.

500MG · DIN 02042932

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

CLOXACILLIN

PRO DOC LIMITEE

500MG · DIN 02069679

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TEGOPEN INJ 500MG/VIAL

BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB

500MG · DIN 00407607

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

ORBENIN INJ 500MG

AYERST LABORATORIES

500MG · DIN 00002178

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

TEVA-CLOXACILLIN

TEVA CANADA LIMITED

250MG · DIN 00337765

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00618284

Strength

500MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

CLOXACILLIN SODIUM

See all CLOXACILLIN SODIUM products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2017-10-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244